ideaPoint Partners with SAS to Provide Leading Data Sharing Solution Through ClinicalStudyDataRequest.com
January 07, 2020 07:00 ET
|
Anaqua
BOSTON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Anaqua’s ideaPoint, a leading provider of innovation management solutions, today has announced a partnership with SAS, the world leader in analytics. The...
Healthcare Predictive Analytics Market To Reach USD 22,390.3 Million By 2026 | Reports And Data
November 11, 2019 21:00 ET
|
Reports and Data
New york, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Exponential increase in healthcare database volume, increasing investments on digital tech to effectively manage available information, rising adoption of...
Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection
October 07, 2019 07:00 ET
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes...
Summit Therapeutics Reports Ridinilazole Significantly Improved Short and Longer-Term Quality of Life Measures in Patients with C. difficile Infection Compared to Standard of Care
October 03, 2019 07:00 ET
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Reports Ridinilazole Significantly Improved Short and Longer-Term Quality of Life Measures in Patients with C. difficile...
Summit Therapeutics to Present Data from Phase 2 Clinical Trial of Ridinilazole at ID Week 2019
September 24, 2019 07:00 ET
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present Data from Phase 2 Clinical Trial of Ridinilazole at ID Week 2019 Oxford, UK, and Cambridge, MA, US,...
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
August 26, 2019 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
New Publication Highlights Transient Increases in Creatinine or Tubular Injury Markers in Heart Failure Patients Should Not Dissuade Use of Ultrafiltration
August 08, 2019 07:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Aug. 08, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today the publication of a study in Circulation Heart Failure1 highlighting the benefits of...
Biothera Pharmaceuticals to Present Clinical Data from Phase 2 Triple Negative Breast Cancer Study at ASCO 2019 Annual Meeting
May 16, 2019 10:00 ET
|
Biothera Pharmaceuticals, Inc.
EAGAN, Minn., May 16, 2019 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc., which is developing a dectin receptor agonist drug known as Imprime PGG, announced today that it will present primary...
Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting
February 21, 2019 07:00 ET
|
Dermavant Sciences, Inc.
Dermavant plans to initiate Phase 3 clinical program evaluating tapinarof for the treatment of psoriasis in the first half of 2019 BASEL, Switzerland and PHOENIX, Feb. 21, 2019 (GLOBE NEWSWIRE) --...
Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit
December 06, 2018 07:00 ET
|
Dermavant Sciences, Inc.
BASEL, Switzerland, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that the company will present new data on cerdulatinib...